第一代Janus激酶抑制剂在类风湿关节炎患者中的持续性和治疗依从性

{"title":"第一代Janus激酶抑制剂在类风湿关节炎患者中的持续性和治疗依从性","authors":"C. Martinez-Molina, N. Pages, P. Riera, A. Riera, H. Codes, C. Díaz-Torné, H. Corominas, J. Ruiz-Ramos, M. Masip","doi":"10.1136/ejhpharm-2022-eahp.405","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":393937,"journal":{"name":"Section 7: Post Congress additions","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"4CPS-215 Persistence and therapeutic adherence to first-generation Janus kinase inhibitors in rheumatoid arthritis patients\",\"authors\":\"C. Martinez-Molina, N. Pages, P. Riera, A. Riera, H. Codes, C. Díaz-Torné, H. Corominas, J. Ruiz-Ramos, M. Masip\",\"doi\":\"10.1136/ejhpharm-2022-eahp.405\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":393937,\"journal\":{\"name\":\"Section 7: Post Congress additions\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 7: Post Congress additions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2022-eahp.405\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 7: Post Congress additions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2022-eahp.405","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}